Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quigley

This article was originally published in The Tan Sheet

Executive Summary

Cold-Eeze marketer looking to recapture zinc lozenge market share in 2001 through private label channel. "We are arranging a private label for various selected chains with whom we do business for Cold-Eeze for the upcoming season," Chairman, President & CEO Guy Quigley tells analysts during recent fiscal 2000 earnings conference call. Doylestown, Penn.-based firm also is refocusing brand marketing on health care professionals. Revenue for FY 2000 was $19.4 mil., down 22% from 1999; net loss was $5.2 mil. compared to $4.2 mil. a year ago. In 10K filed with SEC March 5, Quigley attributes revenue drop to reduced Cold-Eeze sales "due to industry consolidation, store private labeling of zinc products [and] the reduction in the incidence of colds" in Q4. Fourth quarter revenue of $7.7 mil. was down almost 39%
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092287

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel